전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article


References

  1. Holling TM, Schooten E, Den Elsen PJ. 2004. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Hum. Immunol. 65: 282-290.
    Pubmed
  2. Neefjes J, Jongsma ML, Paul P, Bakke O. 2011. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11: 823-836.
    Pubmed
  3. Gaspari AA, Jenkins MK, Katz SI. 1988. Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in haptenspecific Th1 clones. J. Immunol. 141: 2216-2220.
  4. Frasca L, Marelli-Berg F, Imami N, Potolicchio I, Carmichael P, Lombardi G, et al. 1998. Interferon-gamma-treated renal tubular epithelial cells induce allospecific tolerance. Kidney Int. 53: 679-689.
    Pubmed
  5. Bal V, Mclndoe A, Denton G, Hudson D, Lombardi G, Lamb J, et al. 1990. Antigen presentation by keratinocytes induces tolerance in human T cells. Eur. J. Immunol. 20: 1893-1897.
    Pubmed
  6. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388: 782-787.
    Pubmed
  7. Vedrenne J, Assier E, Pereno R, Bouzinba-Segard H, Azzarone B, Jasmin C, et al. 1997. Inhibitor (IK) of IFN-γ induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line. Oncogene 14: 1453-1461.
    Pubmed
  8. Assier E, Bouzinba-Segard H, Stolzenberg MC, Stephens R, Bardos J, Freemont P, et al. 1999. Isolation, sequencing and expression of RED, a novel human gene encoding an acidic-basic dipeptide repeat. Gene 230: 145-154.
  9. Muraoka M, Hasegawa H, Kohno M, Inoue A, Miyazaki T, Terada M, et al. 2006. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum. 54: 3591-3600.
    Pubmed
  10. Park HL, Lee SM, Min JK, Moon SJ, Kim I, Kang KW, et al. 2017. IK acts as an immunoregulator of inflammatory arthritis by suppressing TH17 cell differentiation and macrophage activation. Sci. Rep. 7: 40280.
    Pubmed PMC
  11. Choi S, Park HL, Jung S, Kim EK, Cho ML, Min JK, et al. 2017. Therapeutic effect of exogenous truncated IK protein in inflammatory arthritis. Int. J. Mol. Sci. 18: 1976.
    Pubmed PMC
  12. Shembade N, Harhaj EW. 2012. Regulation of NF-κB signaling by the A20 deubiquitinase. Cell Mol. Immunol. 9: 123-130.
    Pubmed PMC
  13. Lamiable A, Thévenet P, Rey J, Vavrusa M, Derreumaux P, Tufféry P. 2016. PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex. Nucleic Acids Res. 44: W449-W454.
    Pubmed PMC
  14. Evans BC, Nelson CE, Yu SS, Beavers KR, Kim AJ, Li H, et al. 2013. Ex vivo red blood cell hemolysis assay for the evaluation of pHresponsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. J. Vis. Exp. 73: e50166.
    PMC
  15. Molly FC, Sean WD, Mark SW, Colleen MS, Scott AS, Don RP, et al. 2000. Standard practice for assessment of hemolytic properties of materials. American Society for Testing of Materials. ASTM F756-00.
  16. Asadullah K, Sterry W, Volk HD. 2003. Interleukin-10-review of a new approach. Pharmacol. Rev. 55: 241-269.
    Pubmed
  17. Ng TH, Britton GJ, Hill EV, Verhagen J, Burton BR, Wraith DC. 2013. Regulation of adaptive immunity; the role of interleukin-10. Front. Immunol. 4: 129.
  18. Seo S, Miyake H, Alganabi M, Janssen Lok M, O’Connell JS, Lee C, et al. 2019. Vasoactive intestinal peptide decreases inflammation and tight junction disruption in experimental necrotizing enterocolitis. J. Pediatr. Surg. 54: 2520-2523.
    Pubmed
  19. Gaffen SL. 2009. Role of IL-17 in the pathogenesis of rheumatoid arthritis. Curr. Rheumatol. Rep. 11: 365-370.
    Pubmed PMC
  20. Jin W, Dong C. 2013. IL-17 cytokines in immunity and inflammation. Emerg. Microbes Infect. 2: e60.
    Pubmed PMC
  21. Shabgah AG, Fattahi E, Shahneh FZ. 2014. Interleukin-17 human inflammatory diseases. Postepy Dermatol. Alergol. 31: 256-261.
    Pubmed PMC
  22. Paradowska-Gorycka A, Haladyj E. 2015. Th17-cells in the pathogenesis of rheumatoid arthritis. Int. J. Autoimmune Disord. Ther. 1: 337-345.
  23. Niu T, Cheng L, Wang H, Zhu S, Yang X, Liu K, et al. 2019. KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis. J. Neuroinflammation 16: 278.
    Pubmed PMC
  24. Murray PJ. 2005. The primary mechanism of the IL-10-regulated anti-inflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. USA 102: 8686-8691.
    Pubmed PMC
  25. Couper KN, Blount DG, Riley EM. 2009. IL-10: The master regulator of immunity to infection. J. Immunol. 180: 5771-5777.
    Pubmed
  26. Koppelman B, Neefjes JJ, de Vries JE, Malefyt RW. 1997. Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7: 861-871.
  27. Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. 2010. Anti- and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity. Curr. Opin. Pharmacol. 9: 447-453.
    Pubmed PMC
  28. Kelhälä HL, Palatsi R, Fyhrquist N, Lehtimäki S, Väyrynen JP, Kallioinen M, et al. 2014. IL-17/Th17 pathway is activated in acne lesions. PLoS One 9: e105238.
    Pubmed PMC
  29. Chiricozzi A, Guttman-Yassky E, Suárez-Farinas M, Nograles KE, Tian S, Cardinale I, et al. 2011. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J. Invest. Dermatol. 131: 677-687.
    Pubmed
  30. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD. 1998. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 111: 645-649.
    Pubmed
  31. Hilary S, Habib H, Souka U, Ibrahim W, Platat C. 2017. Bioactivity of arid region honey: an in vitro study. BMC Complement Altern. Med. 17: 177.
    Pubmed PMC